For a Vietnamese pharmaceutical manufacturer planning EU market entry, the most expensive question is not, “Can this site pass an EU GMP inspection?”
It is this: Can the existing facility…
If an inspector arrived next quarter, could your leadership team prove that the site is in control without launching a last-minute search for drawings, qualification records, deviations, and missing approvals?…
For Vietnamese manufacturers, EU GMP certification involves defining the intended product and market, aligning with an EU importer and regulatory pathway, closing facility and quality-system gaps, completing qualification and validation,…
Choosing the wrong GMP pathway can delay facility approvals, increase project costs, and restrict access to target export markets. While EU GMP, WHO GMP, and USFDA cGMP share similar quality…
The EU GMP certification process is the practical journey from defining the correct regulatory pathway to demonstrating that a pharmaceutical site, its systems, people, and quality controls can consistently support…
Introduction
The pharmaceutical manufacturing industry operates under some of the most demanding conditions in the world. Precision, compliance, and efficiency are not optional. When a company decides to set up…
Introduction: The Partner Decision That Shapes Everything After It
Before a single wall goes up, before a cleanroom is fitted, before any equipment arrives on site, the most consequential decision…
Introduction: Getting Your Foundation Right From Day One
For first-time pharmaceutical entrepreneurs, setting up a manufacturing facility is the most complex, high-stakes project they will undertake. Unlike most industries, pharmaceutical…
There is a pattern that repeats itself across pharmaceutical facility projects more often than it should.
A facility is designed, built, and equipped. The project team is satisfied with the…
Choosing a pharmaceutical turnkey partner is one of the highest-stakes decisions a manufacturer makes.
Get it right, and you have a facility that is delivered on time, built to regulatory…
When planning a new pharmaceutical manufacturing facility, most project teams focus heavily on one number: the upfront project cost.
It is understandable. Capital expenditure is visible, immediate, and easy to…
